Adcetris, an ADC, receives the health insurance benefit exempted from total amount limit

An antibody-drug conjugate(ADC) has overcame the wall of the health insurance benefit. It also did not get restricted by the total amount limit of the economic evaluation exception.

The Health Insurance Review & Assessment Service advertised the health insurance benefit standard of Takeda Pharmaceuticals Korea’s ‘Adcetris(brentuximab)’ and announced it would collect opinions by the 26^th. If ha...